← back to search

Florentino Luciano Caetano dos Santos

Harvard University · US
Area of research
Oncology · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Global Cancer Incidence and Screening, Global Maternal and Child Health, Cerebrovascular and Carotid Artery Diseases, and COVID-19 and healthcare impacts.
h-index
37
citations
76,317
works
84
NIH funding
primary concept
Medicine
email

Recent publications

Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
2025cited by 61position: contributordoi
Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021.
2025cited by 26position: contributordoi
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.
2025cited by 16position: contributordoi
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
2024cited by 3,311position: contributordoi
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
2024cited by 1,874position: contributordoi
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
2024cited by 1,817position: contributordoi
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
2024cited by 750position: contributordoi
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
2024cited by 716position: contributordoi
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
2024cited by 676position: contributordoi
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
2024cited by 301position: contributordoi
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020
Eye 2024cited by 41position: middledoi
Suicide risk among adolescents and young adults after cancer diagnosis: analysis of 34 cancer groups from 2009 to 2019.
2023cited by 8position: contributordoi
Risk of suicide in patients with cancer aged 75 years or more - Follow-up of over 400,000 individuals.
2023cited by 8position: contributordoi
Changes in the survival of patients with breast cancer: Poland, 2000-2019.
2023cited by 8position: contributordoi
Prognostic Implications of PRAME Expression and Clinicopathological Factors in Sinonasal Mucosal Melanoma: A Single-center Cohort Study of 30 Cases.
2023cited by 6position: contributordoi
Suicide after a Diagnosis of Cancer: Follow-Up of 1.4 Million Individuals, 2009-2019.
2023cited by 4position: contributordoi
Tobacco products and electronic cigarettes' legislation violations - observational study in 31 European countries, 2005-2022.
2023cited by 4position: contributordoi
Survival of patients with cancers of the female genital organs in Poland, 2000-2019.
2023cited by 4position: contributordoi
Effect of preoperative liver-directed therapy prior to hepatic resection.
2023cited by 2position: contributordoi
Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study.
2023cited by 1position: contributordoi
Signet-Ring Cell/Histiocytoid Carcinoma: Report of Two Cases and Systematic Review of the Literature on the Epidemiology, Clinical Characteristics, and Pathological and Molecular Findings.
2023cited by 1position: contributordoi
Favorable changes in the survival of patients with cancers of digestive organs - Poland, 2000-2019.
2023cited by 0position: contributordoi
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
2022cited by 1,460position: contributordoi
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
2022cited by 1,372position: contributordoi
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.
2022cited by 677position: contributordoi
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
2022cited by 213position: contributordoi
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study.
2022cited by 211position: contributordoi
The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
2022cited by 167position: contributordoi
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
2022cited by 162position: contributordoi
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019.
2022cited by 91position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Irmina Maria Michalek · Instituto de Salud Carlos III22 papers (2019–2023) · 10 papers (2019–2023) · 5 papers (2022–2023) · 5 papers (2022–2023)Loris Nanni · University of Padua2 papers (2015–2016) · 2 papers (2015–2016) · 2 papers (2015–2016)Omid Dadras · University of Turku1 papers (2022–2022)Amadou Barrow · University of the Gambia1 papers (2022–2022)Irena M. Ilic · University of Asia Pacific1 papers (2022–2022)Francine Behar-Cohen · Institut Necker Enfants Malades1 papers (2021–2021)Juha Salenius · Tampere University Hospital1 papers (2019–2019)Ejaz Ahmad Khan · Northern Sydney Local Health District1 papers (2022–2022)Monika Prochorec-Sobieszek · Institute of Hematology and Transfusion Medicine1 papers (2023–2023)Muktar Beshir Ahmed · Centre for Cancer Biology1 papers (2022–2022)Michelangelo Paci · Tampere University1 papers (2019–2019)Monika Durzyńska · Maria Sklodowska-Curie National Research Institute of Oncology1 papers (2023–2023)Hannu Eskola · Tampere University1 papers (2019–2019)Jari Hyttinen · Tampere University of Applied Sciences1 papers (2019–2019)Milena D. Ilic · University of Banja Luka1 papers (2022–2022)